Bristol-Myers Squibb Announces Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has commenced a cash tender offer for up to $400 million aggregate principal amount (the “tender cap”) of specified series of its outstanding debt. Pursuant to the tender offer, Bristol-Myers Squibb is offering to purchase, under certain conditions and subject to certain limitations, its 6.125% Notes due 2038, 5.875% Notes due 2036, 6.80% Debentures due 2026 and 7.15% Debentures due 2023 (collectively, the “notes”).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC